Hydralazine Hcl And Hydrochlorothiazide

   
Google
 
Web NewDrugInformation.com

Hydralazine Hcl And Hydrochlorothiazide


Drug - Hydralazine Hcl And Hydrochlorothiazide
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydralazine Hydrochloride; Hydrochlorothiazide
Multiple ingredients are in alphabetical order.

Strength - 50MG;50MG
The potency of the active ingredient(s), Hydralazine Hydrochloride; Hydrochlorothiazide. May repeat for multiple part products.

Applicant - SOLVAY
The firm name holding legal responsibility for Hydralazine Hcl And Hydrochlorothiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 087213
The FDA assigned number to Hydralazine Hcl And Hydrochlorothiazide. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hydralazine Hcl And Hydrochlorothiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 8, 1982
The date Hydralazine Hcl And Hydrochlorothiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hydralazine Hcl And Hydrochlorothiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hydralazine Hcl And Hydrochlorothiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Solvay Pharmaceuticals
The full name of the firm holding legal responsibility for the new application of Hydralazine Hcl And Hydrochlorothiazide.

Hydralazine Hcl And Hydrochlorothiazide